Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT06152523	TitleMonalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer	Fase Fase 2	Date Added 2023-11-30	Ubicación Francia	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas Monalizumab/MEDI5257	Etiquetas MSI-H/ MMRd
NCT ID NCT04444622	TitleImmunotherapy for Third Line Metastatic Colorectal Cancer	Fase Fase 2	Date Added 2020-06-23	Ubicación Florida, United States Michigan, United States New Jersey, United States New York, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT05879822	TitleEstudio para evaluar INCB099280 en participantes con tumores sólidos seleccionados que no han recibido ningún inhibidor de los puntos de control inmunitarios.	Fase Fase 2	Date Added 2023-05-30	Ubicación Brasil China Georgia Greece Hungary Nueva Zelanda Romania Sudáfrica Turkey	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas INCB099280	Etiquetas MSI-H/ MMRd
NCT ID NCT05999812	TitleClinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer	Fase Fase 2	Date Added 2023-08-21	Ubicación Texas, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas all trans Retinoic Acid, Atezolizumab, Bevacizumab	Etiquetas MSS/ MMRp
NCT ID NCT06006923	TitleRegorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer	Fase Fase 2	Date Added 2023-08-23	Ubicación California, United States Florida, United States Illinois, United States Pennsylvania, United States Washington, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Pembrolizumab, Regorafenib, Keytruda, Stivarga	Etiquetas MSI-H/ MMRd
NCT ID NCT06014502	TitleStudy to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors	Fase Fase 1	Date Added 2023-08-28	Ubicación Louisiana, United States Texas, United States	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas IMGS-001	Etiquetas MSI-H/ MMRd
NCT ID NCT06176885	TitleEfficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer	Fase Fase 2	Date Added 2023-12-20	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Camrelizumab	Etiquetas MSS/ MMRp
NCT ID NCT04041310	TitleNous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors	Fase Phase 1, Phase 2	Date Added 2019-08-01	Ubicación California, United States Florida, United States Indiana, United States Maryland, United States Missouri, United States New York, United States Texas, United States Bélgica Canadá Italia España Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas	Etiquetas MSI-H/ MMRd
NCT ID NCT05865535	TitleA Dose Escalation Study of AV-380 in Metastatic Cancer Patients With Cachexia	Fase Fase 1	Date Added 2023-05-19	Ubicación California, United States Florida, United States Georgia, United States Nebraska, United States New York, United States Oregon, United States South Carolina, United States Tennessee, United States Texas, United States	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 291 to 299 of 299 entries